118 related articles for article (PubMed ID: 20979530)
21. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
22. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
[TBL] [Abstract][Full Text] [Related]
23. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
Nakashima K; Taga T
Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
[TBL] [Abstract][Full Text] [Related]
25. Targeting IL-6 trans-signalling: past, present and future prospects.
Rose-John S; Jenkins BJ; Garbers C; Moll JM; Scheller J
Nat Rev Immunol; 2023 Oct; 23(10):666-681. PubMed ID: 37069261
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
27. Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer.
Heo TH; Wahler J; Suh N
Oncotarget; 2016 Mar; 7(13):15460-73. PubMed ID: 26840088
[TBL] [Abstract][Full Text] [Related]
28. A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130.
Hong SS; Choi JH; Lee SY; Park YH; Park KY; Lee JY; Kim J; Gajulapati V; Goo JI; Singh S; Lee K; Kim YK; Im SH; Ahn SH; Rose-John S; Heo TH; Choi Y
J Immunol; 2015 Jul; 195(1):237-45. PubMed ID: 26026064
[TBL] [Abstract][Full Text] [Related]
29. Structure of an extracellular gp130 cytokine receptor signaling complex.
Chow D; He X; Snow AL; Rose-John S; Garcia KC
Science; 2001 Mar; 291(5511):2150-5. PubMed ID: 11251120
[TBL] [Abstract][Full Text] [Related]
30. Caspase-mediated cleavage of the signal-transducing IL-6 receptor subunit gp130.
Graf D; Haselow K; Münks I; Bode JG; Häussinger D
Arch Biochem Biophys; 2008 Sep; 477(2):330-8. PubMed ID: 18593565
[TBL] [Abstract][Full Text] [Related]
31. Targeting Interleukin-6 Signaling in Clinic.
Kang S; Tanaka T; Narazaki M; Kishimoto T
Immunity; 2019 Apr; 50(4):1007-1023. PubMed ID: 30995492
[TBL] [Abstract][Full Text] [Related]
32. Effects of blockade of peripheral interleukin-6 trans-signaling on hippocampus-dependent and independent memory in mice.
Braun O; Dewitz C; Möller-Hackbarth K; Scheller J; Schiffelholz T; Baier PC; Rose-John S
J Interferon Cytokine Res; 2013 May; 33(5):254-60. PubMed ID: 23215755
[TBL] [Abstract][Full Text] [Related]
33. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6.
Bobby R; Robustelli P; Kralicek AV; Mobli M; King GF; Grötzinger J; Dingley AJ
FEBS J; 2014 May; 281(10):2471-83. PubMed ID: 24712547
[TBL] [Abstract][Full Text] [Related]
34. Epithelial gp130/Stat3 functions: an intestinal signaling node in health and disease.
Ernst M; Thiem S; Nguyen PM; Eissmann M; Putoczki TL
Semin Immunol; 2014 Feb; 26(1):29-37. PubMed ID: 24434062
[TBL] [Abstract][Full Text] [Related]
35. Deletion of interleukin-6 signal transducer gp130 in small sensory neurons attenuates mechanonociception and down-regulates TRPA1 expression.
Malsch P; Andratsch M; Vogl C; Link AS; Alzheimer C; Brierley SM; Hughes PA; Kress M
J Neurosci; 2014 Jul; 34(30):9845-56. PubMed ID: 25057188
[TBL] [Abstract][Full Text] [Related]
36. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
37. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
38. Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.
Burger R; Günther A; Klausz K; Staudinger M; Peipp M; Penas EM; Rose-John S; Wijdenes J; Gramatzki M
Haematologica; 2017 Feb; 102(2):381-390. PubMed ID: 27658435
[TBL] [Abstract][Full Text] [Related]
39. Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis.
Sackett SD; Otto T; Mohs A; Sander LE; Strauch S; Streetz KL; Kroy DC; Trautwein C
FASEB J; 2019 May; 33(5):6035-6044. PubMed ID: 30726111
[TBL] [Abstract][Full Text] [Related]
40. Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling.
Espígol-Frigolé G; Planas-Rigol E; Ohnuki H; Salvucci O; Kwak H; Ravichandran S; Luke B; Cid MC; Tosato G
Sci Signal; 2016 Mar; 9(419):ra28. PubMed ID: 26980441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
